Stratified medicine and reimbursement issues (Q36317504)

13 August 2017

Stratified medicine and reimbursement issues (English)

1 reference

13 August 2017

Hans-Joerg Fugel

1

1 reference

PMCID

3471319

13 August 2017

Mark Nuijten

series ordinal

2

1 reference

PMCID

3471319

13 August 2017

Maarten Postma

series ordinal

3

1 reference

13 August 2017

15 October 2012

1 reference

Frontiers in Pharmacology

13 August 2017

1 reference

13 August 2017

3

1 reference

13 August 2017

181

1 reference

Cost effectiveness of pharmacogenomics: a critical and systematic review.

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471319

Economic opportunities and challenges for pharmacogenomics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471319

Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471319

Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471319

Personalized medicine and the practice of medicine in the 21st century.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471319

Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471319

Personalized medicine: factors influencing reimbursement.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471319

When do new biomarkers make economic sense?

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471319

The microeconomics of personalized medicine: today's challenge and tomorrow's promise

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3471319

Linking pharmacogenetics-based diagnostics and drugs for personalized medicine

22 September 2018

1 reference

12 December 2020

Realizing the promise of personalized medicine

1 reference

12 December 2020

Health technology assessments in personalized medicine: illustrations for cost-effectiveness analysis

1 reference

12 December 2020

Molecular diagnostics and personalized medicine: value-assessed opportunities for multiple stakeholders

1 reference

12 December 2020

Market access challenges in the EU for high medical value diagnostic tests

1 reference

12 December 2020

Identifiers

DOI

10.3389/FPHAR.2012.00181

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

PMCID

3471319